STAT+: After fight over cancer clinicians, Dana-Farber and Brigham are playing nice again
Stat News • 3/10/2026
Summary
Dana-Farber and Brigham have agreed to cooperate on a “mutually acceptable and coordinated plan” following a dispute over cancer clinicians. The two hospitals are now working together amicably.
Advertisement
Lindy Score Breakdown (V4.2)
1d
Age
1
Sources
from cluster
34
Hours Since Seen
Final Score9/100
CategoryAntiLindy
StatusActive
Recency Multiplier61% (0.5^34/48)
Hero EligibleYes
Score BreakdownRisk 65
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 1 day(s) old - still early
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: A setback for Roche’s breast cancer drug
Stat News • 2 days ago
STAT+: GOP senator is investigating the FDA over rejections of rare disease drugs
Stat News • 1 day ago
Opinion: STAT+: The Himsification of medicine
Stat News • 1 day ago
STAT+: Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial
Stat News • 2 days ago
STAT+: Blue Cross Blue Shield says data back up claim that AI is driving up medical bills
Stat News • 2 days ago
STAT+: The ER staffing conflict, and no facility fee for a marmot
Stat News • 2 days ago
STAT+: Health tech company says it will dive into Medicare’s new chronic care experiment
Stat News • 2 days ago
STAT+: FDA approves leucovorin for rare disorder without trial data
Stat News • Today
STAT+: Pharmalittle: We’re reading about the FDA warning Novo Nordisk, Lilly investing in China, and more
Stat News • Today
STAT+: BioNTech founders to depart, form new mRNA-focused company
Stat News • 1 day ago